Stay Informed

Sign up for news & alerts

Already signed up?
Login here

take action
For every $1 states spend dollar sign on substance misuse and addiction, 94 cents go to shovel up the consequences instead of for treatment and prevention. TELL YOUR LEGISLATORS

What Can I Do?



Continuing Education
Free online courses for addiction counselors LEARN ONLINE

Get Help
Need alcohol or drug help for yourself or someone else? GET HELP

 
'Abuse-Resistant' OxyContin Under Development
November 14, 2005

Share Share Email
Email
Print
Print
SubscribeSubscribe
News Summary

A pharmaceutical company has purchased the rights to Remoxy, a version of the controversial painkiller OxyContin designed to thwart abuse of the drug, the New York Times reported Nov. 10.

Biotechnology firm Pain Therapeutics could reap up to $300 million from the deal with King Pharmaceuticals, which will attempt to take Remoxy to market by 2007. Both Remoxy and OxyContin are designed as slow-release drugs, but Remoxy encases its narcotic active ingredients in a sticky substance that makes it difficult to crush, snort, inject, or dissolve in alcohol.

Final-stage clinical trials of the drug are scheduled for January 2006.

COMMENTS ON THIS ARTICLE:

SUBMIT A COMMENT:

Note: Comments are now held for moderator approval. More info

Name:

Comment:
(limit 250
words)
Enter this word
(help):		 Change

GUIDELINES: 
Please keep comments on-topic, courteous, clean, non-commercial, and within the word limit.
Read the complete guidelines